Is the oral route possible for peptide and protein drug delivery?
- PMID: 16997140
- DOI: 10.1016/j.drudis.2006.08.005
Is the oral route possible for peptide and protein drug delivery?
Abstract
Oral delivery of peptides and proteins remains an attractive alternative to parenteral delivery and has challenged various attempts at delivery development. Incorporation of new tools into the delivery systems that can raise membrane permeability of macromolecules is essential to attain high oral bioavailability that is acceptable in clinical applications. In developing oral protein delivery systems with high bioavailability, three practical approaches might be most helpful: (1) modification of the physicochemical properties of macromolecules; (2) addition of novel function to macromolecules; or (3) use of improved delivery carriers. Clearly, it is essential that these approaches maintain the biological activity of the proteins.
Similar articles
-
Oral biodrug delivery using cell-penetrating peptide.Adv Drug Deliv Rev. 2012 May 1;64(6):531-9. doi: 10.1016/j.addr.2011.12.014. Epub 2012 Jan 4. Adv Drug Deliv Rev. 2012. PMID: 22245080 Review.
-
Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.Crit Rev Ther Drug Carrier Syst. 1994;11(2-3):119-60. Crit Rev Ther Drug Carrier Syst. 1994. PMID: 7600586 Review.
-
Commercial challenges of protein drug delivery.Expert Opin Drug Deliv. 2005 Jan;2(1):29-42. doi: 10.1517/17425247.2.1.29. Expert Opin Drug Deliv. 2005. PMID: 16296733 Review.
-
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.Curr Opin Pharmacol. 2006 Oct;6(5):509-14. doi: 10.1016/j.coph.2006.04.004. Epub 2006 Jul 24. Curr Opin Pharmacol. 2006. PMID: 16860608 Review.
-
Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.Pharmazie. 1997 May;52(5):339-45. Pharmazie. 1997. PMID: 9183784 Review.
Cited by
-
Preparation and characterization of collagen microspheres for sustained release of VEGF.J Mater Sci Mater Med. 2010 Jun;21(6):1891-8. doi: 10.1007/s10856-010-4054-0. Epub 2010 Mar 16. J Mater Sci Mater Med. 2010. PMID: 20232232
-
The future of open- and closed-loop insulin delivery systems.J Pharm Pharmacol. 2008 Jan;60(1):1-13. doi: 10.1211/jpp.60.1.0001. J Pharm Pharmacol. 2008. PMID: 18088499 Free PMC article. Review.
-
Oral delivery of RNAi for cancer therapy.Cancer Metastasis Rev. 2023 Sep;42(3):699-724. doi: 10.1007/s10555-023-10099-x. Epub 2023 Mar 27. Cancer Metastasis Rev. 2023. PMID: 36971908 Free PMC article. Review.
-
Peptidomimetic therapeutics: scientific approaches and opportunities.Drug Discov Today. 2017 Feb;22(2):454-462. doi: 10.1016/j.drudis.2016.11.003. Epub 2016 Nov 14. Drug Discov Today. 2017. PMID: 27856346 Free PMC article. Review.
-
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives.Saudi Pharm J. 2016 Jul;24(4):413-28. doi: 10.1016/j.jsps.2014.06.004. Epub 2014 Jun 16. Saudi Pharm J. 2016. PMID: 27330372 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
